1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet. Med. 14(Suppl. 5): S1–S85 (1997)
2. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemoth. Rep. 29: 91–98 (1963)
3. Bhattacharya G. On the protection against alloxan diabetes by hexoses. Science 120: 841–843 (1954)
4. Schein PS, Rakieten N, Cooney DA, Davis R, Vernon ML. Streptozotocin diabetes in monkeys and dogs, and its prevention by nicotinamide. Proc. Soc. Exp. Biol. Med. 143: 514–518 (1973)
5. Matkovics B, Kotorman M, Varga IS, Hai DQ, Varga C. Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol. Hung. 85: 29–38 (1997)